Global Nerve Repair and Regeneration Market was valued at $5,928 million in 2021 and is anticipated to grow at $13,939 million till 2028 recording a CAGR of 13.1% during the forecast period 2021-2028. The number of incidence of peripheral nerve injury cases due to trauma, accidents, or nerve damage cases are increasing day by day leading to increased demand of novel diagnostic and treatment methods. For instance, In Canada and US the primary cause of nerve damage is motor vehicle accidents, annually, 26-46% people in US, 52% in Toronto, 43% in Brazil and 26.9 % in Turkey suffers from nerve damage, Europe accounts for about 300,000 cases of traumatic PNI per annum and in India, trauma is one of the leading causes of death and disability with 400,000 road crashes, 85,000 deaths, and 1.2 million seriously injured cases annually. Global nerve repair & regeneration industry is surging owing to frequent acquisitions, product approval, collaborations, and product launches by the market players. For instance, In November 2017, the Stryker Corporation received humanitarian device exemption approval from the US Food and Drug Administration for its Neuroform Atlas stent system.